LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - Capsule
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sleep Initiation and Maintenance Disorders
Conditions
Sleep Initiation and Maintenance Disorders
Trial Timeline
Sep 1, 2009 → Mar 1, 2010
NCT ID
NCT01784614About LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - Capsule
LY2624803 - Solution + LY2624803 - Capsule + Placebo - Solution + Placebo - Capsule is a phase 1 stage product being developed by Eli Lilly for Sleep Initiation and Maintenance Disorders. The current trial status is completed. This product is registered under clinical trial identifier NCT01784614. Target conditions include Sleep Initiation and Maintenance Disorders.
What happened to similar drugs?
20 of 20 similar drugs in Sleep Initiation and Maintenance Disorders were approved
Approved (20) Terminated (2) Active (0)
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01784614 | Phase 1 | Completed |
Competing Products
20 competing products in Sleep Initiation and Maintenance Disorders